Trials / Completed
CompletedNCT05652582
Seroprevalence of Covid-19 in the Staff of the University Hospitals of Strasbourg
Seroprevalence of SARS-CoV 2 in the Staff of the University Hospitals of Strasbourg
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 5,694 (actual)
- Sponsor
- University Hospital, Strasbourg, France · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- —
Summary
The Grand Est region is one of the most affected regions in France during the first wave of the COVID-19 epidemic. A significant increase in the number of patients hospitalized for SARS-CoV 2 infection at the University Hospitals of Strasbourg (HUS) led to a sudden saturation of their capacities. Hospital workers appear to be a population at particular risk for this new infectious agent. The percentage of hospital workers who have been in contact with the virus or have contracted COVID-19 is unknown. The objective of this work is to determine the prevalence of SARS-CoV-2 positive serologies among hospital staff screened from June 22, 2020 to November 1, 2020 following a screening campaign offering serological testing to all volunteer HUS professionals.
Conditions
Timeline
- Start date
- 2021-06-24
- Primary completion
- 2022-04-24
- Completion
- 2022-06-24
- First posted
- 2022-12-15
- Last updated
- 2023-12-11
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT05652582. Inclusion in this directory is not an endorsement.